StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$0.11+0.00 (+1.81%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Cellyan Biotechnology free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -$787.07K, down 257.6% from the year before.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$787.07K-257.6%
FY2025Mar 31, 2025$499.30K–
FY2024Mar 31, 2024-$447.07K-127.7%
FY2023Mar 31, 2023$1.61M–

More Cellyan Biotechnology figures

See a number that looks wrong?